Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Amortizatization of Intangibles (2016 - 2021)

Historic Amortizatization of Intangibles for Dexcom (DXCM) over the last 13 years, with Q3 2021 value amounting to $22.0 million.

  • Dexcom's Amortizatization of Intangibles rose 138.25% to $22.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $88.4 million, marking a year-over-year increase of 3684.21%. This contributed to the annual value of $49.6 million for FY2019, which is 17709.5% up from last year.
  • As of Q3 2021, Dexcom's Amortizatization of Intangibles stood at $22.0 million, which was up 138.25% from $22.5 million recorded in Q2 2021.
  • Dexcom's Amortizatization of Intangibles' 5-year high stood at $22.5 million during Q2 2021, with a 5-year trough of $100000.0 in Q1 2017.
  • In the last 5 years, Dexcom's Amortizatization of Intangibles had a median value of $12.2 million in 2019 and averaged $10.9 million.
  • As far as peak fluctuations go, Dexcom's Amortizatization of Intangibles soared by 360000.0% in 2018, and later soared by 138.25% in 2021.
  • Dexcom's Amortizatization of Intangibles (Quarter) stood at $3.7 million in 2017, then soared by 78.38% to $6.6 million in 2018, then soared by 90.91% to $12.6 million in 2019, then skyrocketed by 72.22% to $21.7 million in 2020, then rose by 1.38% to $22.0 million in 2021.
  • Its Amortizatization of Intangibles stands at $22.0 million for Q3 2021, versus $22.5 million for Q2 2021 and $22.2 million for Q1 2021.